These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 19555243

  • 1. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
    Zugasti ME, Zornoza A, Goñi Mdel M, Isasi JR, Vélaz I, Martín C, Sánchez M, Martínez-Ohárriz MC.
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
    [Abstract] [Full Text] [Related]

  • 2. Influence of cyclodextrin complexation on piroxicam gel formulations.
    Jug M, Bećirević-Laćan M, Kwokal A, Cetina-Cizmek B.
    Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
    [Abstract] [Full Text] [Related]

  • 3. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
    Jug M, Bećirević-Laćan M, Cetina-Cizmek B, Horvat M.
    Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
    [Abstract] [Full Text] [Related]

  • 4. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ, Windberg-Baarup A, Neri C, Byway PV, Booth SW, Fitzpatrick S.
    Int J Pharm; 2007 Jun 07; 337(1-2):246-53. PubMed ID: 17306477
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH, Tazeen J, Merchant HA, Yousuf RI.
    Pak J Pharm Sci; 2006 Apr 07; 19(2):119-24. PubMed ID: 16751122
    [Abstract] [Full Text] [Related]

  • 6. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
    Jug M, Bećirević-Laćan M.
    Eur J Pharm Sci; 2004 Feb 07; 21(2-3):251-60. PubMed ID: 14757497
    [Abstract] [Full Text] [Related]

  • 7. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov 07; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 8. Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.
    Chakraborty S, Khandai M, Sharma A, Patra ChN, Patro VJ, Sen KK.
    Acta Pharm; 2009 Sep 07; 59(3):313-23. PubMed ID: 19819827
    [Abstract] [Full Text] [Related]

  • 9. Controlled release polymeric ocular delivery of acyclovir.
    Deshpande PB, Dandagi P, Udupa N, Gopal SV, Jain SS, Vasanth SG.
    Pharm Dev Technol; 2010 Sep 07; 15(4):369-78. PubMed ID: 19772377
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.
    Kou W, Cai C, Xu S, Wang H, Liu J, Yang D, Zhang T.
    Int J Pharm; 2011 May 16; 409(1-2):75-80. PubMed ID: 21371541
    [Abstract] [Full Text] [Related]

  • 11. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS, Quadir MA, Haider SS.
    J Pharm Pharm Sci; 2003 May 16; 6(2):282-91. PubMed ID: 12935440
    [Abstract] [Full Text] [Related]

  • 12. Hydroxypropyl chitosan bearing beta-cyclodextrin cavities: synthesis and slow release of its inclusion complex with a model hydrophobic drug.
    Prabaharan M, Mano JF.
    Macromol Biosci; 2005 Oct 20; 5(10):965-73. PubMed ID: 16208630
    [Abstract] [Full Text] [Related]

  • 13. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers. II. Effect of HPMC with different degrees of methoxy/hydroxypropyl substitution.
    Escudero JJ, Ferrero C, Jiménez-Castellanos MR.
    Int J Pharm; 2010 Mar 15; 387(1-2):56-64. PubMed ID: 19969052
    [Abstract] [Full Text] [Related]

  • 14. Studies on solubility and hypoglycemic activity of gliclazide beta-cyclodextrin-hydroxypropylmethylcellulose complexes.
    Aggarwal S, Singh PN, Mishra B.
    Pharmazie; 2002 Mar 15; 57(3):191-3. PubMed ID: 11933849
    [Abstract] [Full Text] [Related]

  • 15. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
    Li FQ, Hu JH.
    Yao Xue Xue Bao; 2004 May 15; 39(5):389-91. PubMed ID: 15338886
    [Abstract] [Full Text] [Related]

  • 16. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S, Bodmeier R.
    Int J Pharm; 2010 Dec 15; 402(1-2):72-7. PubMed ID: 20883759
    [Abstract] [Full Text] [Related]

  • 17. In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets.
    Ribeiro L, Ferreira DC, Veiga FJ.
    J Control Release; 2005 Mar 21; 103(2):325-39. PubMed ID: 15763617
    [Abstract] [Full Text] [Related]

  • 18. Influence of beta-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets.
    Koester LS, Xavier CR, Mayorga P, Bassani VL.
    Eur J Pharm Biopharm; 2003 Jan 21; 55(1):85-91. PubMed ID: 12551708
    [Abstract] [Full Text] [Related]

  • 19. The effect of substitution pattern of HPMC on polymer release from matrix tablets.
    Viridén A, Larsson A, Wittgren B.
    Int J Pharm; 2010 Apr 15; 389(1-2):147-56. PubMed ID: 20100556
    [Abstract] [Full Text] [Related]

  • 20. Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy.
    Ammar HO, Salama HA, Ghorab M, Mahmoud AA.
    Int J Pharm; 2006 Aug 31; 320(1-2):53-7. PubMed ID: 16701974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.